SHARESIFT
Healthcare · data ~15-min delayed
1,779.5 GBp -0.86%
| Price | 1,779.5 GBp |
| Day change | -0.86% |
| Market cap | 71.31B |
| 52-week range | 1,592 – 2,282 |
| P/E (trailing) | 15.1 |
| Dividend yield | 3.82% |
| Payout ratio | 56.88% |
| Return on equity | 33.38% |
| Debt / equity | 106% |
| Beta | 0.29 |
| Sector | Healthcare |
| Value score | 49 / 100 |
How the value score is calculated: 13 published tests, weighted to 100.
GSK plc (GSK.L) scores 49/100 on this site's value model, a middling reading with some valuation measures favourable and others not. It trades at 15.1 times trailing earnings and is classified in Healthcare. The dividend yield is 3.82%, paid from 57% of earnings. Return on equity is 33%, with debt at 106% of equity. On its filings it passes 8 of the nine Piotroski checks, which points to improving fundamentals. Its Altman Z-Score places it in the grey zone. These are automated readings of reported figures, not a recommendation.
Piotroski F-Score 8 / 9 — nine pass/fail checks on profitability, leverage and efficiency, comparing the latest financial year with the one before.
Altman Z-Score 2.09 — Grey zone.
Updated · prices ~15-min delayed, fundamentals as last reported
Open full interactive analysis →See how it ranks: UK stocks by value score
Value scoring · Piotroski F-Score · Altman Z · technicals · dividends — free, no sign-up.